You are here

Gilead's Covid-19 antiviral remdesivir gets conditional EU clearance

rk_remdesivir_030720.jpg
The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe Covid-19 patients following an accelerated review process, making it the region's first therapy to be authorised to treat the virus.

[BRUSSELS] The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe Covid-19 patients following an accelerated review process, making it the region's first therapy to be authorised to treat the virus.

The move comes just a week...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes